These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 15170354)
1. Active site residues in Mycobacterium tuberculosis pantothenate synthetase required in the formation and stabilization of the adenylate intermediate. Zheng R; Dam TK; Brewer CF; Blanchard JS Biochemistry; 2004 Jun; 43(22):7171-8. PubMed ID: 15170354 [TBL] [Abstract][Full Text] [Related]
2. Alanine mutation of the catalytic sites of Pantothenate Synthetase causes distinct conformational changes in the ATP binding region. Pandey B; Grover S; Goyal S; Kumari A; Singh A; Jamal S; Kaur J; Grover A Sci Rep; 2018 Jan; 8(1):903. PubMed ID: 29343701 [TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the pantothenate synthetase from Mycobacterium tuberculosis, snapshots of the enzyme in action. Wang S; Eisenberg D Biochemistry; 2006 Feb; 45(6):1554-61. PubMed ID: 16460002 [TBL] [Abstract][Full Text] [Related]
5. Positional isotope exchange analysis of the pantothenate synthetase reaction. Williams L; Zheng R; Blanchard JS; Raushel FM Biochemistry; 2003 May; 42(17):5108-13. PubMed ID: 12718554 [TBL] [Abstract][Full Text] [Related]
6. Crystal structures of a pantothenate synthetase from M. tuberculosis and its complexes with substrates and a reaction intermediate. Wang S; Eisenberg D Protein Sci; 2003 May; 12(5):1097-108. PubMed ID: 12717031 [TBL] [Abstract][Full Text] [Related]
8. X-ray crystallographic and NMR studies of pantothenate synthetase provide insights into the mechanism of homotropic inhibition by pantoate. Chakrabarti KS; Thakur KG; Gopal B; Sarma SP FEBS J; 2010 Feb; 277(3):697-712. PubMed ID: 20059543 [TBL] [Abstract][Full Text] [Related]
9. The design and synthesis of inhibitors of pantothenate synthetase. Tuck KL; Saldanha SA; Birch LM; Smith AG; Abell C Org Biomol Chem; 2006 Oct; 4(19):3598-610. PubMed ID: 16990935 [TBL] [Abstract][Full Text] [Related]
10. Substrate-induced closing of the active site revealed by the crystal structure of pantothenate synthetase from Staphylococcus aureus. Satoh A; Konishi S; Tamura H; Stickland HG; Whitney HM; Smith AG; Matsumura H; Inoue T Biochemistry; 2010 Aug; 49(30):6400-10. PubMed ID: 20568730 [TBL] [Abstract][Full Text] [Related]
11. A novel isoform of pantothenate synthetase in the Archaea. Ronconi S; Jonczyk R; Genschel U FEBS J; 2008 Jun; 275(11):2754-64. PubMed ID: 18422645 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the dynamics of pantothenate synthetase from M. tuberculosis and E. coli: computational studies. Tan YS; Fuentes G; Verma C Proteins; 2011 Jun; 79(6):1715-27. PubMed ID: 21425349 [TBL] [Abstract][Full Text] [Related]
13. Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase. Xu Z; Yin W; Martinelli LK; Evans J; Chen J; Yu Y; Wilson DJ; Mizrahi V; Qiao C; Aldrich CC Bioorg Med Chem; 2014 Mar; 22(5):1726-35. PubMed ID: 24507827 [TBL] [Abstract][Full Text] [Related]
14. Relationship between activating and editing functions of the adenylation domain of apo-tyrocidin synthetase 1 (apo-TY1). Bucević-Popović V; Pavela-Vrancic M; Dieckmann R; Von Döhren H Biochimie; 2006; 88(3-4):265-70. PubMed ID: 16182433 [TBL] [Abstract][Full Text] [Related]
15. Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues. Chad JM; Sarathy KP; Gruber TD; Addala E; Kiessling LL; Sanders DA Biochemistry; 2007 Jun; 46(23):6723-32. PubMed ID: 17511471 [TBL] [Abstract][Full Text] [Related]
16. The final step of pantothenate biosynthesis in higher plants: cloning and characterization of pantothenate synthetase from Lotus japonicus and Oryza sativum (rice). Genschel U; Powell CA; Abell C; Smith AG Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):669-78. PubMed ID: 10417331 [TBL] [Abstract][Full Text] [Related]
17. Enzymatic characterization and crystal structure analysis of the D-alanine-D-alanine ligase from Helicobacter pylori. Wu D; Zhang L; Kong Y; Du J; Chen S; Chen J; Ding J; Jiang H; Shen X Proteins; 2008 Sep; 72(4):1148-60. PubMed ID: 18320587 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of lumazine synthase from Mycobacterium tuberculosis as a target for rational drug design: binding mode of a new class of purinetrione inhibitors. Morgunova E; Meining W; Illarionov B; Haase I; Jin G; Bacher A; Cushman M; Fischer M; Ladenstein R Biochemistry; 2005 Mar; 44(8):2746-58. PubMed ID: 15723519 [TBL] [Abstract][Full Text] [Related]
19. Three-dimensional structures of apo- and holo-L-alanine dehydrogenase from Mycobacterium tuberculosis reveal conformational changes upon coenzyme binding. Agren D; Stehr M; Berthold CL; Kapoor S; Oehlmann W; Singh M; Schneider G J Mol Biol; 2008 Apr; 377(4):1161-73. PubMed ID: 18304579 [TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis pantothenate kinase: possible changes in location of ligands during enzyme action. Chetnani B; Das S; Kumar P; Surolia A; Vijayan M Acta Crystallogr D Biol Crystallogr; 2009 Apr; 65(Pt 4):312-25. PubMed ID: 19307712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]